The immune contexture in STS tumors is marked by specific features, including tumor-associated macrophages (TAM), dysfunctional tumor-infiltrating lymphocytes (TIL), reduced CD8 T cell and NK cell activity, increased Treg cells, limited B cell infiltration, and impaired dendritic cell (DC) function (17–20). This evidence concerns the gene CD8A and neoplasm.